Literature DB >> 9163525

CCAAT/enhancer-binding protein delta gene expression is mediated by APRF/STAT3.

T Yamada1, K Tobita, S Osada, T Nishihara, M Imagawa.   

Abstract

The CCAAT/enhancer-binding protein delta (C/EBP delta) transcription factor is known to be rarely expressed but sharply induced at an early stage of the acute phase response. To investigate the regulation mechanisms for this induction, the 5'-flanking region of the rat C/EBP delta gene was isolated. Functional analyses involving transfection and footprinting indicated that the upstream region up to - 175 bp is sufficient for the full basal activity in rat fibroblast 3Y1 cells. At least three cis-elements including a GC box are involved in this activity. When HepG2 cells were treated with interleukin-6 (IL-6), C/EBP delta mRNA was rapidly induced. Transfection and gel shift analyses identified the binding site for the acute phase response factor/signal transducers and activators of transcription (APRF/STAT3). These findings strongly indicate that C/EBP delta gene expression is mediated by APRF/STAT3, which is phosphorylated for the activation through the IL-6 receptor when cells are treated with IL-6, and trans-activates the other acute phase response genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163525     DOI: 10.1093/oxfordjournals.jbchem.a021647

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  Expression, DNA-binding specificity and transcriptional regulation of nuclear factor 1 family proteins from rat.

Authors:  S Osada; T Matsubara; S Daimon; Y Terazu; M Xu; T Nishihara; M Imagawa
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

Review 2.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

3.  A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Authors:  J S Park; L Qiao; D Gilfor; M Y Yang; P B Hylemon; C Benz; G Darlington; G Firestone; P B Fisher; P Dent
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

4.  HUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression.

Authors:  K Okumura; G Sakaguchi; K Naito; T Tamura; H Igarashi
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

Review 5.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes.

Authors:  W Briest; B Rassler; A Deten; M Leicht; R Morwinski; D Neichel; G Wallukat; T Ziegelhöffer; H-G Zimmer
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

7.  C/EBPalpha is critical for the neonatal acute-phase response to inflammation.

Authors:  B L Burgess-Beusse; G J Darlington
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 8.  Hepatocytes: a key cell type for innate immunity.

Authors:  Zhou Zhou; Ming-Jiang Xu; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-12-21       Impact factor: 11.530

9.  Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-delta gene in hepatocytes.

Authors:  Saira Ali; Nishi N Singh; Hatice Yildirim; Dipak P Ramji
Journal:  Int J Biochem Cell Biol       Date:  2009-09-30       Impact factor: 5.085

10.  Reciprocal regulation of p63 by C/EBP delta in human keratinocytes.

Authors:  Serena Borrelli; Barbara Testoni; Maurizio Callari; Daniela Alotto; Carlotta Castagnoli; Rose-Anne Romano; Satrajit Sinha; Alessandra M Viganò; Roberto Mantovani
Journal:  BMC Mol Biol       Date:  2007-09-28       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.